All data is delayed
See More

Pfizer withdraws life-threatening drug

Dec 10 2010 16:55

New York - US pharmaceutical giant Pfizer announced on Friday it is pulling off the market its blood pressure drug Thelin due to a potentially life-threatening risk of liver injury.

Pfizer said it was voluntarily withdrawing Thelin in the European Union, Canada and Australia and is also suspending all clinical tests on the anti-hypertension drug.

"While liver toxicity is a known complication of the class of drugs to which Thelin belongs, a new potentially life-threatening idiosyncratic risk of liver injury with Thelin has been observed," Pfizer said in a statement.

"Given the availability of alternate treatments, Pfizer has concluded that the overall benefit of Thelin no longer outweighs the risk in the general population of PAH (pulmonary arterial hypertension) patients."

The company said it had notified health authorities about its findings and its decision to withdraw Thelin from the market and stop clinical studies.

pfizer  |  medicines


Read Fin24’s Comments Policy publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.

Comment on this story
Comments have been closed for this article.

Company Snapshot

We're talking about:


With infrastructure spending having been identified as one of the key focus areas of the National Development Plan, tradesmen will continue to play a critical role in growing the South African economy through their skills..

Money Clinic

Money Clinic
Do you have a question about your finances? We'll get an expert opinion.
Click here...

Voting Booth

A 30% a month return on investment is:

Previous results · Suggest a vote